UNIV OF TX SOUTHWESTERN COMPREHENSIVE MED SICKLE CELL CT

中心概述 西南综合镰刀细胞中心(简称中心)，被列为十大中心之一 在2003-2008年的赠款周期内，由NHLBI资助的中心正在申请在下一个赠款周期继续提供支持 资金周期。该中心设在德克萨斯大学达拉斯西南医学中心(UT) 西南大学)和达拉斯儿童医学中心(CMCD)将继续包括其他合作 医疗中心，其医生和其他人员致力于照顾镰状细胞患者 疾病和进行新的临床、翻译和卫生服务研究。这些其他中心 是德克萨斯大学达拉斯分校、俄克拉荷马大学健康科学中心、达拉斯大学 加尔维斯顿的德克萨斯医学分校和佛罗里达大学医学院。中心的轨道 CSCC临床试验联盟在当前授权期内的记录堪称典范。中心 到目前为止，研究人员领导着五项国家临床试验中的两项，并在 财团委员会。此外，我们中心的多个站点的临床试验登记已经完成 相当可观。该中心目前在十大综合性中心中排名第二。 招生。该中心还成功地开展了基础科学、临床内部中心和各种 其他协作和机构研究协议，并伴随着顺利运作的行政管理 和患者服务核心。该中心计划继续并显著扩大无数项研究，患者 未来五年的护理、教育和宣传举措。具有凝聚力、互动性和 中心调查人员及其机构之间存在合作精神，从而确保西南地区 综合镰刀细胞中心的持续成功。

Center Overview The Southwestern Comprehensive Sickle Cell Center (the "Center"), which has served as one of the ten NHLBI-funded Centers during 2003-2008 grant cycle, is applying for continued support during the next funding cycle. The Center, based at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) and Children's Medical Center Dallas (CMCD), will continue to include other collaborating medical centers whose physicians and other personnel are dedicated to the care of persons with sickle cell disease and the conduct of novel clinical, translational, and health services research. These other Centers are the University of Texas at Dallas, the University of Oklahoma Health Sciences Center, the University of Texas Medical Branch at Galveston, and the University of Florida College of Medicine. The Center's track record during the current grant period in the CSCC Clinical Trials Consortium has been exemplary. Center investigators lead two of the five national clinical trials opened thus far and play prominent roles on Consortium committees. Moreover, clinical trial enrollment from the multiple sites in our Center has been substantial. The Center currently ranks second overall among the ten comprehensive centers in patient enrollment. The Center is also successfully executing basic science, clinical intra-Center, and a variety of other collaborative and institutional research protocols, accompanied by smoothly functioning administrative and patient services cores. The Center plans to continue and appreciably expand myriad research, patient care, education, and advocacy initiatives during the next five years. A cohesive, interactive, and collaborative spirit exists among Center investigators and their institutions, thus assuring the Southwestern Comprehensive Sickle Cell Center's continued success.